Comparison of Salivary Biormarkers Levels With Periodontal Clinical Parameters in Smokers and Non-Smokers With Different Periodontal Diseases

计划入组 80 人 · 首次发布于 2024 年 6 月 14 日

DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone

计划入组 31 人 · 首次发布于 2020 年 4 月 24 日

Imaging Core Aim 2, and Udall Project 2 Aim 2

计划入组 20 人 · 首次发布于 2025 年 5 月 31 日

neuropilin 1 antagonists

anti-neuropilin-1 antibody

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

Science Translational Medicine Validates Efzofitimod's Novel Mechanism for Treating Lung Inflammation

Novel Pipeline Therapies Show Promise for Pulmonary Sarcoidosis Treatment

Phase 2 Trial Shows Promise for Efzofitimod in Reducing Steroid Dependence in Sarcoidosis Patients